Form 4 for GH Guardant Health, Inc.
Accepted 2025-02-18 00:00:00 ET · period of report 2025-02-15 · accession 0001576280-25-000040 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-02-18 | 2025-02-15 | GH | POTTER MYRTLE S | Dir | M - OptEx | $0.00 | +68 | 13.9K | +0.5% | $0 |
| D | 2025-02-18 | 2025-02-15 | GH | POTTER MYRTLE S | Dir | M - OptEx | $0.00 | -68 | 548 | -11% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-15 | M | A | 68 | $0.00 | 13,858 | D | — | — | |
| 2 | Derivative | Restricted Stock Units | 2025-02-15 | M | D | 68 | $0.00 | 548 | D | $0.00 · — to — | 68 Common Stock | (F1) The restricted stock unit award vested as to 25% of the shares subject to such award on October 15, 2022, and the remaining 75% vests in substantially equal installments on each monthly anniversary of October 15, 2022, during the three-year period thereafter. (F2) Not applicable for Restricted Stock Units. |